W.L. Gore & Associates announced today that the FDA approved its Viabahn Fortegra venous stent, formerly known as Viafort.

FDA approves first venous stent for IVC and iliofemoral veins, offering a new treatment for deep venous disease with proven 12-month patency.

W. L. Gore & Associates' medical business (Gore) has announced the FDA approval of the GORE® VIABAHN® FORTEGRA Venous Stent — ...

W. L. Gore & Associates has secured FDA approval for the GORE VIABAHN FORTEGRA Venous Stent — previously known as the GORE ...

The investigational device evaluated in the trial, previously known as the GORE ® VIAFORT Vascular Stent, will now be referred to as the GORE ® VIABAHN ® FORTEGRA Venous Stent. CAUTION: ...

New device size comes in response to physicians’ requests for additional offerings to expand treatment options FLAGSTAFF, Ariz.,W. L. Gore & Associates (Gore) today announced the availability of a new ...

The GORE VIABAHN Endoprosthesis portfolio spans a wide variety of sizes, including the recently added 7.5 cm and 25 cm length versions, the industry’s longest such device. The dynamic range of options ...

July 15, 2005 — The U.S. Food and Drug Administration (FDA) has approved single- and dual-chamber versions of an implantable cardioverter defibrillator that feature managed ventricular pacing and ...

Improvements to large diameter devices include accessibility through smaller sheaths while providing enhanced visualization by adding radiopaque markers 25 years of continued innovation PUTZBRUNN, ...

Please provide your email address to receive an email when new articles are posted on . The U.S Food and Drug Administration has granted indication for the Viabahn Endoprosthesis, made by W. L. Gore & ...

FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) is celebrating the 20 th anniversary of the introduction of the GORE® VIABAHN® Endoprosthesis, the market-leading stent-graft ...